Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity

Although expression of inducible NO synthase (iNOS) in the lungs of asthmatics and associated nitrosative damage are established, iNOS failed as a therapeutic target for blocking airway hyperresponsiveness (AHR) and inflammation in asthmatics. This dichotomy calls for better strategies with which th...

Full description

Saved in:
Bibliographic Details
Main Authors: Salome’ V. Ibba, Mohamed A. Ghonim, Kusma Pyakurel, Matthew R. Lammi, Anil Mishra, A. Hamid Boulares
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2016/1984703
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561104764534784
author Salome’ V. Ibba
Mohamed A. Ghonim
Kusma Pyakurel
Matthew R. Lammi
Anil Mishra
A. Hamid Boulares
author_facet Salome’ V. Ibba
Mohamed A. Ghonim
Kusma Pyakurel
Matthew R. Lammi
Anil Mishra
A. Hamid Boulares
author_sort Salome’ V. Ibba
collection DOAJ
description Although expression of inducible NO synthase (iNOS) in the lungs of asthmatics and associated nitrosative damage are established, iNOS failed as a therapeutic target for blocking airway hyperresponsiveness (AHR) and inflammation in asthmatics. This dichotomy calls for better strategies with which the enzyme is adequately targeted. Here, we confirm iNOS expression in the asthmatic lung with concomitant protein nitration and poly(ADP-ribose) polymerase (PARP) activation. We show, for the first time, that iNOS is highly expressed in peripheral blood mononuclear cells (PBMCs) of asthmatics with uncontrolled disease, which did not correspond to protein nitration. Selective iNOS inhibition with L-NIL protected against AHR upon acute, but not chronic, exposure to ovalbumin or house dust mite (HDM) in mice. Supplementation of NO by nitrite administration significantly blocked AHR in chronically HDM-exposed mice that were treated with L-NIL. Protection against chronic HDM exposure-induced AHR by olaparib-mediated PARP inhibition may be associated with the partial but not the complete blockade of iNOS expression. Indeed, L-NIL administration prevented olaparib-mediated protection against AHR in chronically HDM-exposed mice. Our study suggests that the amount of iNOS and NO are critical determinants in the modulation of AHR by selective iNOS inhibitors and renews the potential of iNOS as a therapeutic target for asthma.
format Article
id doaj-art-989c7b6ab1eb435ca527f623bebc0b2e
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-989c7b6ab1eb435ca527f623bebc0b2e2025-02-03T01:25:56ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/19847031984703Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP ActivitySalome’ V. Ibba0Mohamed A. Ghonim1Kusma Pyakurel2Matthew R. Lammi3Anil Mishra4A. Hamid Boulares5The Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USAThe Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USAThe Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USAPulmonary/Critical Care and Allergy/Immunology Section, School of Medicine, Louisiana State University, New Orleans, LA 70112, USAEosinophilic Disorder Center in the Section of Pulmonary Diseases, Tulane University School of Medicine, New Orleans, LA 70112, USAThe Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USAAlthough expression of inducible NO synthase (iNOS) in the lungs of asthmatics and associated nitrosative damage are established, iNOS failed as a therapeutic target for blocking airway hyperresponsiveness (AHR) and inflammation in asthmatics. This dichotomy calls for better strategies with which the enzyme is adequately targeted. Here, we confirm iNOS expression in the asthmatic lung with concomitant protein nitration and poly(ADP-ribose) polymerase (PARP) activation. We show, for the first time, that iNOS is highly expressed in peripheral blood mononuclear cells (PBMCs) of asthmatics with uncontrolled disease, which did not correspond to protein nitration. Selective iNOS inhibition with L-NIL protected against AHR upon acute, but not chronic, exposure to ovalbumin or house dust mite (HDM) in mice. Supplementation of NO by nitrite administration significantly blocked AHR in chronically HDM-exposed mice that were treated with L-NIL. Protection against chronic HDM exposure-induced AHR by olaparib-mediated PARP inhibition may be associated with the partial but not the complete blockade of iNOS expression. Indeed, L-NIL administration prevented olaparib-mediated protection against AHR in chronically HDM-exposed mice. Our study suggests that the amount of iNOS and NO are critical determinants in the modulation of AHR by selective iNOS inhibitors and renews the potential of iNOS as a therapeutic target for asthma.http://dx.doi.org/10.1155/2016/1984703
spellingShingle Salome’ V. Ibba
Mohamed A. Ghonim
Kusma Pyakurel
Matthew R. Lammi
Anil Mishra
A. Hamid Boulares
Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity
Mediators of Inflammation
title Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity
title_full Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity
title_fullStr Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity
title_full_unstemmed Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity
title_short Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity
title_sort potential of inducible nitric oxide synthase as a therapeutic target for allergen induced airway hyperresponsiveness a critical connection to nitric oxide levels and parp activity
url http://dx.doi.org/10.1155/2016/1984703
work_keys_str_mv AT salomevibba potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity
AT mohamedaghonim potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity
AT kusmapyakurel potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity
AT matthewrlammi potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity
AT anilmishra potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity
AT ahamidboulares potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity